Cargando…
Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines
The DNA methyltransferase inhibitors azacytidine and decitabine represent archetypal drugs for epigenetic cancer therapy. To characterize the demethylating activity of azacytidine and decitabine we treated colon cancer and leukemic cells with both drugs and used array-based DNA methylation analysis...
Autores principales: | Hagemann, Sabine, Heil, Oliver, Lyko, Frank, Brueckner, Bodo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049766/ https://www.ncbi.nlm.nih.gov/pubmed/21408221 http://dx.doi.org/10.1371/journal.pone.0017388 |
Ejemplares similares
-
Antiproliferative Effects of DNA Methyltransferase 3B Depletion Are Not Associated with DNA Demethylation
por: Hagemann, Sabine, et al.
Publicado: (2012) -
Comprehensive comparison between azacytidine and decitabine treatment in an acute myeloid leukemia cell line
por: Aumer, Tina, et al.
Publicado: (2022) -
A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
por: Griffin, Patrick T., et al.
Publicado: (2016) -
The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization
por: Massah, S., et al.
Publicado: (2020) -
DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire
por: Nie, Jing, et al.
Publicado: (2016)